Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Wound healing effects of exosomes from hypoxia- and normoxia-expanded adipose-derived stem cells of infant and adult origin.

Wu SH., Hsueh KK., Liao YT., Cheng MT., Tao ZX., Wang JP.

Animal Study on Chronic Wound, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Stem Cell Res Ther (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41013578
PMCID
PMC12465689
DOI
10.1186/s13287-025-04636-4
Citations
2

Abstract (original English)

Background Exosomes derived from adipose-derived stem cells (ADSC-Exos) have emerged as promising therapeutic agents for promoting wound healing through paracrine mechanisms. While adult ADSC-Exos have been extensively studied, those derived from infant ADSCs have received limited attention, despite their potentially superior regenerative capacity. In addition, hypoxia preconditioning has been shown to enhance the therapeutic efficacy of stem cells and their secretome; however, its influence on exosome function across different donor ages remains unclear. This study aimed to evaluate and compare the wound healing effects of ADSC-Exos from adult and infant sources expanded under hypoxic and normoxic conditions in a diabetic mouse model. Methods ADSC-Exos were isolated from adult and infant donors cultured under normoxic and hypoxic conditions. Exosomes were characterized by morphology, transmission electron microscopy (TEM) imaging, nanoparticle tracking analysis (NTA), and Western blotting. RNA sequencing was performed to profile miRNAs encapsulated in the exosomes. In vitro assays assessed the effects of exosomes on proliferation, migration, and wound healing in human dermal fibroblasts (HDFs) under high-glucose conditions. In vivo efficacy was evaluated using full-thickness wounds in db/db diabetic mice to assess the therapeutic effects of the exosomes. Results Normoxic infan

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
ExosomesWound HealingHumansAnimalsMiceAdipose TissueAdultCell HypoxiaInfantStem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research